Alzheimer’s disease is one of the most common causes of memory loss in older adults. It slowly affects the brain, making it harder for people to remember things, think clearly, and carry out daily activities.
As the global population ages, more and more families are facing the challenges of this condition. Because of this, scientists around the world are working hard to understand how Alzheimer’s develops and how it can be detected earlier and treated more effectively.
Traditionally, research on Alzheimer’s disease has focused on what happens inside the brain. One of the main features scientists look for is the buildup of amyloid plaques.
These are sticky clumps of protein that collect between brain cells and are believed to interfere with normal brain function. For many years, these plaques have been seen as a key sign of Alzheimer’s disease.
However, a new study from researchers at Emory University’s Goizueta Brain Health Institute suggests that the story may be much more complex. The study, published in the journal Nature Aging, shows that important changes may also be happening outside the brain, especially in the blood.
In this large study, scientists examined blood samples from more than 2,100 people. These participants were part of several major Alzheimer’s research programs, including Emory’s own studies, the Bio-Hermes study, and the Religious Orders Study and the Rush Memory and Aging Project.
By combining data from these different groups, researchers were able to get a broader and more detailed picture of how Alzheimer’s may affect the body.
The research team used advanced laboratory tools to measure thousands of proteins in the blood. Proteins are important molecules that help carry out many functions in the body, such as supporting the immune system, providing energy, and maintaining the structure of tissues.
By studying these proteins, scientists hoped to find patterns that are linked to memory loss and thinking problems.
The results were surprising. The researchers found that several groups of proteins in the blood were strongly connected to cognitive decline.
These included proteins related to the immune system, which helps protect the body from disease, as well as proteins involved in how the body produces energy, removes waste, and maintains its structural support system, known as the extracellular matrix.
Even more interesting was the discovery that many of these protein changes could not be fully explained by what is seen in the brain.
In other words, the usual signs of Alzheimer’s, such as amyloid plaques, did not account for all the changes observed in the blood. This suggests that processes happening in other parts of the body may play an important role in how Alzheimer’s begins and progresses.
One of the study’s lead researchers, Dr. Erik Johnson, explained that many of the proteins found in the blood are not directly linked to the changes seen in brain tissue after death. This means that the rest of the body, not just the brain, may influence the development of Alzheimer’s disease.
This idea opens up new possibilities for treatment. If Alzheimer’s is affected by processes throughout the body, then future therapies may not need to focus only on the brain. Instead, doctors might be able to target these changes in the blood to slow down or even prevent the disease.
Dr. Allan Levey, executive director of the Goizueta Brain Health Institute, said that the findings help identify which blood proteins are connected to Alzheimer’s. This could lead to the development of simple blood tests that can detect the disease much earlier than current methods.
Early detection is very important. Many treatments work best when started before symptoms become severe. If doctors can identify Alzheimer’s in its early stages using a blood test, patients may have a better chance of slowing the disease and maintaining their quality of life.
Another major advantage of blood tests is that they are less invasive than current diagnostic methods. Today, diagnosing Alzheimer’s often requires brain scans or spinal fluid tests, which can be expensive and uncomfortable. A simple blood test would be much easier and more accessible for many people.
Although more research is needed, this study provides strong evidence that Alzheimer’s disease is not just a brain disorder, but a condition that involves the whole body. It also highlights the importance of looking beyond traditional markers and exploring new ways to understand and treat the disease.
The findings from this research bring new hope that, in the future, Alzheimer’s could be detected earlier, monitored more easily, and treated more effectively. By studying the body as a whole, scientists may be able to uncover new paths to better health and longer, more independent lives for people at risk of this condition.
If you care about Alzheimer’s, please read studies about Vitamin D deficiency linked to Alzheimer’s, vascular dementia, and Oral cannabis extract may help reduce Alzheimer’s symptoms.
For more information about brain health, please see recent studies about Vitamin B9 deficiency linked to higher dementia risk, and results showing flavonoid-rich foods could improve survival in Parkinson’s disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
